Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(12 sites)
United States
RWJBarnabas Health Clara Maas Medical Center, Belleville, New Jersey Trinitas Hospital and Comprehensive Cancer Center, Elizabeth, New Jersey RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton, Hamilton, New Jersey RWJBarnabas Health Jersey City Medical Center, Jersey City, New Jersey Cooperman Barnabas Medical Center, Livingston, New Jersey Jack and Sheryl Morris Cancer Center, New Brunswick, New Jersey RWJBarnabas Health - Robert Wood Johnson University Hospita, New Brunswick, New Jersey Cancer Center Initiative, Newark, New Jersey University Hospital, Newark, New Jersey RWJBarnabas Health Newark Beth Israel Medical Center, Newark, New Jersey RWJBarnabas Health - Robert Wood Johnson University Hospital Somerset, Somerville, New Jersey RWJBarnabas Health - Community Medical Center, Toms River, New Jersey